Alteryx price target raised to $32 from $30 at Piper Sandler

Piper Sandler analyst Brent Bracelin raised the firm’s price target on Alteryx to $32 from $30 and keeps an Underweight rating on the shares. Improving internal execution and tighter cost controls during Q3 are encouraging steps in the right direction, but don’t change the heightened execution and model risks tied to a challenging IT environment and shifting data landscape bound to be reshaped by generative AI, the firm says.